miércoles, 31 de julio de 2019

Brand–brand competition unlikely to lower list prices of brand-name drugs

Brand–brand competition unlikely to lower list prices of brand-name drugs

News-Medical

Brand–brand competition unlikely to lower list prices of brand-name drugs

Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women’s Hospital and Harvard Medical School, and colleagues.

No hay comentarios:

Publicar un comentario